[1] HILL N R, FATOBA S T, OKE J L, et al. Global prevalence of chronic kidney disease - a systematic review and meta-analysis[J]. PLoS One, 2016,11(7):e0158765. [2] LI L C, LEE Y T, LEE Y W,et al.Aortic arch calcification predicts the renal function progression in patients with stage 3 to 5 chronic kidney disease[J]. Biomed Res Int, 2015:131263. [3] HERON M. Deaths: leading causes for 2007[J]. Natl Vital Stat Rep, 2011, 59(8):1-95. [4] TIMOFTE D, TANASESCU M D, BALAN D G, et al. Management of acute intradialytic cardiovascular complications: Updated overview (Review)[J]. Exp Ther Med, 2021,21(3):282. [5] CETIN M S, OZCAN CETIN E H, KALENDER E, et al. Monocyte to HDL cholesterol ratio predicts coronary artery disease severity and future major cardiovascular adverse events in acute coronary syndrome[J]. Heart Lung Circ, 2016,25(11): 1077-1086. [6] QUAGLINO D, BORALDI F, LOFARO F D. The biology of vascular calcification[J]. Int Rev Cell Mol Biol,2020,354:261-353. [7] GIRNDT M, TROJANOWICZ B, ULRICH C. Monocytes in Uremia[J]. Toxins: Basel,2020,12(5):340. [8] AKBOGA M K, BALCI K G, MADEN O, et al. Usefulness of monocyte to HDL-cholesterol ratio to predict high SYNTAX score in patients with stable coronary artery disease[J]. Biomark Med,2016,10(4):375-383. [9] KANBAY M, SOLAK Y, UNAL H U, et al. Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease[J]. Int Urol Nephrol, 2014,46(8):1619-1625. [10] OWAKI A, INAGUMA D, TANAKA A,et al. Evaluation of the relationship between the serum alkaline phosphatase level at dialysis initiation and all-cause mortality: a multicenter, prospective study[J]. Nephron Extra,2017,7(3):78-88. [11] CHEN Z, ZHANG X, HAN F, et al. High alkaline phosphatase and low intact parathyroid hormone associate with worse clinical outcome in peritoneal dialysis patients[J]. Perit Dial Int, 2021,41(2):236-243. |